Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29562705 | 1.00 | GABRA1 (0.44) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL6275225 | 0.86 | GABRA1 (0.57) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL9016954 | 0.83 | GABRA1 (0.48) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL4447955 | 0.80 | TAAR1 (0.41) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL217088 | 0.78 | — | — | |
| SCHEMBL4449960 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL629949 | 0.77 | TAAR1 (0.38) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL11104057 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL4896383 | 0.77 | GABRA1 (0.42) | GABRA1GABRB2TAAR1IDO1TSHR | |
| SCHEMBL6042969 | 0.77 | GABRA1 (0.42) | GABRA1GABRB2TAAR1IDO1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110475796-B | Composition for optical material | 三菱瓦斯化学株式会社 | 2022-02-15 | — | — | CN | disclosed |
| US-11186673-B2 | Composition for use as optical material | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20200223975-A1 | COMPOSITION FOR USE AS OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-07-16 | — | — | US | disclosed |
| US-8470860-B2 | Phenyl-sulfamates as aromatase inhibitors | STERIX LIMITED (GB) | 2013-06-25 | — | — | US | disclosed |
| EP-1966166-B1 | 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS | STERIX LTD (GB) | 2013-01-23 | — | — | EP | disclosed |
| US-8093279-B2 | Compound | STERIX LIMITED (GB) | 2012-01-10 | — | — | US | disclosed |
| US-8022224-B2 | 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors | STERIX LIMITED (GB) | 2011-09-20 | — | — | US | disclosed |
| US-7922934-B2 | s-Indacene and indeno[5,6-d][1,3]dioxol-derivatives and use thereof as components of liquid-crystal mixtures | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-04-12 | — | — | US | disclosed |
| US-20110021586-A1 | PHENYL-SULFAMATES AS AROMATASE INHIBITORS | STERIX, LIMITED (GB) | 2011-01-27 | — | — | US | disclosed |
| US-7763642-B2 | Phenyl-sulfamates as aromatase inhibitors | STERIX LTD. (GB) | 2010-07-27 | — | — | US | disclosed |
| EP-0401296-B1 | RIGID-ROD POLYMERS | MAXDEM INC (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5659005-A | Rigid-rod polymers | MAXDEM INCORPORATED (US) | 1997-08-19 | — | — | US | disclosed |
| US-5565543-A | Rigid-rod polymers | MAXDEM INCORPORATED (US) | 1996-10-15 | — | — | US | disclosed |
| US-5227457-A | Rigid-rod polymers | MAXDEM INCORPORATED (US) | 1993-07-13 | — | — | US | disclosed |
| EP-0489085-A4 | RIGID-ROD POLYMERS | MAXDEM INC (US) | 1992-08-05 | — | — | EP | disclosed |
| EP-0489085-A1 | RIGID-ROD POLYMERS | MAXDEM INCORPORATED (US) | 1992-06-10 | — | — | EP | disclosed |
| EP-0401296-A4 | RIGID-ROD POLYMERS | MAXDEM INC (US) | 1992-03-18 | — | — | EP | disclosed |
| WO-1991002764-A1 | RIGID-ROD POLYMERS | MAXDEM INCORPORATED (US) | 1991-03-07 | — | — | WO | disclosed |
| EP-0401296-A1 | RIGID-ROD POLYMERS | MAXDEM INCORPORATED (US) | 1990-12-12 | — | — | EP | disclosed |
| WO-1989007617-A1 | RIGID-ROD POLYMERS | MAXDEM INCORPORATED (US) | 1989-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021586-A1 | PHENYL-SULFAMATES AS AROMATASE INHIBITORS | CYP19A1, CYP17A1, CYP21A2 | GABRA1 1488/4885GABRB2 889/4885TAAR1 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.